Abvc Biopharma (ABVC) Other Non-Current Assets (2010 - 2026)

Abvc Biopharma (ABVC) has reported Other Non-Current Assets for 15 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 62.57% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (up 62.57% YoY), and the FY2025 full-year result was $1.1 million, changed 0.0% from the prior year.
• Other Non-Current Assets eased to $1.1 million in Q2 2026 per ABVC's latest filing, from $1.8 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.7 million in Q4 2023 and bottomed at $103218.0 in Q3 2022.
• Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $691900.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 995.02% in 2022, then slumped 83.23% in 2024.
• Over 5 years, Other Non-Current Assets stood at $1.3 million in 2022, then soared by 413.46% to $6.7 million in 2023, then plunged by 83.23% to $1.1 million in 2024, then changed by 0.0% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.1 million, $1.8 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.